# Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System

Study · id `cardio:ct-nct03271710` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03271710](<https://clinicaltrials.gov/study/NCT03271710>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03271710

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 113 participants.

## Technical summary

Registry record NCT03271710. Allocation not applicable; no masking; primary purpose treatment. Start 2017-09-01 (actual); primary completion 2018-11-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 113 participants (enrolled count; ClinicalTrials.gov record NCT03271710, source copy `cardio:ctgov-nct03271710-2019-07-10`, retrieved 2026-10-31)
- Started: 2017-09-01 (actual) (ClinicalTrials.gov record NCT03271710, source copy `cardio:ctgov-nct03271710-2019-07-10`, retrieved 2026-10-31)
- Primary completion: 2018-11-30 (actual) (ClinicalTrials.gov record NCT03271710, source copy `cardio:ctgov-nct03271710-2019-07-10`, retrieved 2026-10-31)
- Completion: 2018-12-30 (actual) (ClinicalTrials.gov record NCT03271710, source copy `cardio:ctgov-nct03271710-2019-07-10`, retrieved 2026-10-31)
- Countries: Belgium; Germany (ClinicalTrials.gov record NCT03271710, source copy `cardio:ctgov-nct03271710-2019-07-10`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03271710-2019-07-10`, retrieved 2026-10-31)

## The registry's words

- Brief title: Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System
- Acronym: ENTRAP
- Condition: Peripheral Arterial Disease
- Condition: Intermittent Claudication
- Condition: Atherosclerosis of Femoral Artery
- Intervention (Device): peripheral balloon angioplasty
- Lead sponsor: Contego Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Contego Medical, Inc. (`cardio:org-contego-medical-inc`)

## Provenance

Content hash: 5b3f2f9872424fc5653308e6e5691cca13aa452668ae5c93d7437659ebd435a1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
